Burcin (she/her) is a neuroscientist, data analyst, science writer, and biotech consultant based in Los Angeles. She is passionate about enabling and communicating scientific discoveries for treating, preventing, and managing neurodegenerative diseases using new data-driven tools and technologies. Currently, Burcin works as an application scientist at the Chan Zuckerberg Initiative, where she develops new tools to support patient-driven research for patients with rare diseases. In addition, she writes for Psychology Today about the latest scientific research on neurodegenerative diseases and what they mean to patients. Previously, she has initiated motor neuron disease research efforts at Regeneron Pharmaceuticals, helped create a neurodegeneration program at the Chan Zuckerberg Initiative, and led preclinical development for several biotech startups. She got her B.Sc. in Biomedical Computation from Stanford University and her Ph.D. in Neurobiology from Columbia University.